Novartis , the world's biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. Read the full story

ARIAD Pharmaceuticals signs pharma deals with big pharma Otsuka to commercialize ARIAD’s Iclusig (ponatinib) in Japan and nine other Asian countries and to fund future clinical trials in those countries. Read the full story

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals. Read the full story

Triphase Accelerator announced a new strategic pharma deal with Celgene. Read the full story

Medivation has signed pharma licensing deal for exclusive worldwide rights to CureTech's late-stage clinical molecule pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody. Read the full story

Cardiorentis announced a pharma partnership with Roche to establish the therapeutic efficacy and safety of Ularitide. Read the full story

Astellas Pharma announced a pharma alliance with an investigator at Harvard Medical School focused on discovering the pathologic mechanism for retinitis pigmentosa and identification of new therapeutic targets. Read the full story

The bioinformatics partnering deal trend analysis 2009 to 2014 are reviewed in this article. Read the full story

MacroGenics and Takeda Pharmaceutical announced inking a pharma licensing deal to develop and commercialize four potential product candidates. Read the full story

MetaSysX announce the closure of a pharma deal with Bayer CropScience for the coming three years to apply its metabolomics technologies for improving agricultural productivity. Read the full story